UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000041263 |
|---|---|
| Receipt number | R000047121 |
| Scientific Title | Prospective multicenter observational study of atezolizumab combination therapy in patients with unresectable, advanced and recurrent non-small cell lung cancer or extensive disease small cell lung cancer |
| Date of disclosure of the study information | 2020/08/01 |
| Last modified on | 2025/01/24 10:55:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2020/07/30 19:54:46 | ||
| 2 | Update | 2020/10/16 16:25:53 | Recruitment status |
|
| 3 | Update | 2022/03/22 08:29:43 | Recruitment status |
|
| 4 | Update | 2022/07/25 10:09:51 | Key secondary outcomes Key secondary outcomes |
|
| 5 | Update | 2022/07/25 10:14:14 | Organization Division name Division name Organization Organization Division name Division name Organization Organization Division name Division name |
|
| 6 | Update | 2022/07/25 10:16:03 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
| 7 | Update | 2023/01/31 09:11:36 | Date trial data considered complete Date analysis concluded |
|
| 8 | Update | 2025/01/24 10:55:13 | Recruitment status |
